SynthesisFrontiers in oncology2022

Progression-Free Survival and Time to Progression as Potential Surrogate Endpoints for Overall Survival in Chemoradiotherapy Trials in Limited-Stage Small-Cell Lung Cancer: A Systematic Review and Meta-Analysis.

Yin Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.